Work

Substance use disorders in outpatients with bipolar disorder and pain complaints

Year: 2025
Type: article
Study design: Observational Study
Abstract: INTRODUCTION: Pain and substance use disorders (SUDs) are common in bipolar disorder (BD), yet the associations between these comorbid conditions are poorly understood. Our hypotheses were: (1) the frequency of SUDs may vary according to pain intensity in individuals with BD, (2) individuals with BD, pain and SUDs may have specific characteristics, and (3) clinical variables could explain the associations between pain and SUDs. METHOD: We included outpatients from the FACE-BD cohort with a lifetime diagnosis of BD type I or II. Current pain was categorized using one item of the EQ-5D-5L scale as "no pain", "mild pain", "moderate pain", and "severe or extreme pain". Associations between pain level and other variables were tested using bivariate analyses, while multiple regression was conducted to characterize individuals with BD, pain and relevant SUDs. Finally, path analysis was performed to examine whether clinical variables could explain the associations between pain and relevant SUDs. RESULTS: Among the 1897 BD participants, 927 reported any pain (48.9 %). Among SUDs, higher pain levels were only associated with a history of lifetime alcohol use disorder (AUD). Only individuals with both AUD and moderate to extreme pain had a greater risk of having a history of lifetime anxiety disorder and panic disorder. In path analysis, the association between lifetime AUD and pain was partly mediated by current levels of depression, anxiety, and affective lability. CONCLUSION: Our study highlights multiple associations in individuals with BD between the intensity of reported pain and history of lifetime AUD.
Institutions: Centre National de la Recherche Scientifique, Institut Pascal, Université Clermont Auvergne, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont Auvergne INP, Inserm, Université Paris Cité, Fondation FondaMental, Assistance Publique – Hôpitaux de Paris, Hôpital Fernand-Widal, Optimisation Thérapeutique en Neuropsychopharmacologie, Physiopathologie et pharmacologie de la douleur et de la migraine, Université Paris-Est Créteil, Institut Mondor de Recherche Biomédicale, Centre Hospitalier Charles Perrens, Université de Bordeaux, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, NutriNeuro, Princess Grace Hospital Centre, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Institut de Neurosciences de la Timone, Hôpital Louis-Mourier, Sorbonne Paris Cité, Institut de Psychiatrie et Neurosciences de Paris, Université de Versailles Saint-Quentin-en-Yvelines, Université Paris-Saclay, Centre de recherche en Epidémiologie et Santé des Populations, Centre Hospitalier de Versailles, Centre Hospitalier Universitaire de Grenoble, Grenoble Institute of Neurosciences, Lyon 1 Université, Centre de Recherche en Neurosciences de Lyon, Centre Hospitalier Le Vinatier, Université de Montpellier, Hôpital Lapeyronie, Institut de Génomique Fonctionnelle, Centre Hospitalier Universitaire de Besançon, Hôpitaux Universitaires Henri-Mondor, Centre Hospitalier Régional Universitaire de Brest, Centre Hospitalier Universitaire de Toulouse
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,790
OpenAlex ID: W4411396356
FWCI:
Cites: 51
Cited by:
Related to: 10